Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joy Grant

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Nucleic Acids Research|August 22, 2020
PINCER: improved CRISPR/Cas9 screening by efficient cleavage at conserved residuesBrendan Veeneman, Ying Gao, Joy Grant, et al.
Cell Stem Cell|June 5, 2025
Preferential tumor targeting of HER2 by iPSC-derived CAR T cells engineered to overcome multiple barriers to solid tumor efficacyMartin P Hosking, Soheila Shirinbak, Kyla Omilusik, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Nucleic Acids Research|August 22, 2020
PINCER: improved CRISPR/Cas9 screening by efficient cleavage at conserved residuesBrendan Veeneman, Ying Gao, Joy Grant, et al.
Cell Stem Cell|June 5, 2025
Preferential tumor targeting of HER2 by iPSC-derived CAR T cells engineered to overcome multiple barriers to solid tumor efficacyMartin P Hosking, Soheila Shirinbak, Kyla Omilusik, et al.
Pageof 1